Masaaki Sawa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

Scientific reports

Expert opinion on therapeutic patents

Arteriosclerosis, thrombosis, and vascular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Takayuki Irie, Masaaki Sawa
CDC7 kinase inhibitors: a survey of recent patent literature (2017-2022). Expert opinion on therapeutic patents (2023)
Miruto Tanaka, Shinsuke Nakamura, Tomohisa Sakaue, Takumi Yamamoto, Masashi Maekawa, Anri Nishinaka, Hiroto Yasuda, Kaori Yunoki, Yuji Sato, Masaaki Sawa, Kohichiro Yoshino, Masamitsu Shimazawa, Masahiko Hatano, Takeshi Tokuhisa, Shigeki Higashiyama, Hideaki Hara
BCL6B (B-Cell CLL/Lymphoma 6 Member B Protein) Contributes to Ocular Vascular Diseases via Notch Signal Silencing. Arteriosclerosis, thrombosis, and vascular biology (2023)
Wataru Kawahata, Tokiko Asami, Takao Kiyoi, Takayuki Irie, Shigeki Kashimoto, Hatsuo Furuichi, Masaaki Sawa
Discovery of AS-1763: A Potent, Selective, Noncovalent, and Orally Available Inhibitor of Bruton's Tyrosine Kinase. Journal of medicinal chemistry 64 (19) (2021)
Takayuki Irie, Tokiko Asami, Ayako Sawa, Yuko Uno, Chika Taniyama, Yoko Funakoshi, Hisao Masai, Masaaki Sawa
Discovery of AS-0141, a Potent and Selective Inhibitor of CDC7 Kinase for the Treatment of Solid Cancers. Journal of medicinal chemistry 64 (19) (2021)
Kyoko Miyamoto, Masaaki Sawa
Development of Highly Sensitive Biosensors of RAF Dimerization in Cells. Scientific reports 9 (1) (2019)
Sayuri Ito, Hidemasa Goto, Kinue Kuniyasu, Mayumi Shindo, Masayuki Yamada, Kozo Tanaka, Gaik-Theng Toh, Masaaki Sawa, Masaki Inagaki, Jiri Bartek, Hisao Masai
Cdc7 kinase stimulates Aurora B kinase in M-phase. Scientific reports 9 (1) (2019)
Wataru Kawahata, Tokiko Asami, Takao Kiyoi, Takayuki Irie, Haruka Taniguchi, Yuko Asamitsu, Tomoko Inoue, Takahiro Miyake, Masaaki Sawa
Design and Synthesis of Novel Amino-triazine Analogues as Selective Bruton's Tyrosine Kinase Inhibitors for Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry 61 (19) (2018)
Joost C M Uitdehaag, Jeffrey J Kooijman, Jeroen A D M de Roos, Martine B W Prinsen, Jelle Dylus, Nicole Willemsen-Seegers, Yusuke Kawase, Masaaki Sawa, Jos de Man, Suzanne J C van Gerwen, Rogier C Buijsman, Guido J R Zaman
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017. Molecular cancer therapeutics 18 (2) (2018)
Mari Masuda, Yuko Uno, Naomi Ohbayashi, Hirokazu Ohata, Ayako Mimata, Mutsuko Kukimoto-Niino, Hideki Moriyama, Shigeki Kashimoto, Tomoko Inoue, Naoko Goto, Koji Okamoto, Mikako Shirouzu, Masaaki Sawa, Tesshi Yamada
TNIK inhibition abrogates colorectal cancer stemness. Nature communications 7 (2016)

Masaaki Sawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masaaki Sawa